A new drug strategy that regulates the tumor immune ##microenvironment may make resistant ##PancreaticCancer ##tumors responsive to ##immunotherapy.
##CombinationTherapy ##EpigeneticDrugs ##ImmuneResponse
##CombinationTherapy ##EpigeneticDrugs ##ImmuneResponse
Drug combination prompts immune response in some resistant pancreatic cancers – BioNews Central
A new drug strategy that regulates the tumor immune microenvironment may make resistant pancreatic cancer tumors responsive to immunotherapy. ...
sbee.link
November 24, 2024 at 5:53 AM
A new drug strategy that regulates the tumor immune ##microenvironment may make resistant ##PancreaticCancer ##tumors responsive to ##immunotherapy.
##CombinationTherapy ##EpigeneticDrugs ##ImmuneResponse
##CombinationTherapy ##EpigeneticDrugs ##ImmuneResponse
This review summarizes the role of epigenetic modifications in the #TumorMicroenvironment, the antagonism of #cancer progression by #epigeneticdrugs, and highlights the clinical application and advantages of epigenetic drug combination strategies in cancer development. #medsky
buff.ly/25vP8mQ
buff.ly/25vP8mQ
April 17, 2025 at 12:30 AM
This review summarizes the role of epigenetic modifications in the #TumorMicroenvironment, the antagonism of #cancer progression by #epigeneticdrugs, and highlights the clinical application and advantages of epigenetic drug combination strategies in cancer development. #medsky
buff.ly/25vP8mQ
buff.ly/25vP8mQ
This review provides an overview of the structure and biological function of SET domain-containing 2 (#SETD2) and summarizes the implication of SETD2 dysregulation in #immunedisorders and the progress of several #epigeneticdrugs that target SETD2. #medsky
#OpenAccess: buff.ly/uGOcth3
#OpenAccess: buff.ly/uGOcth3
April 10, 2025 at 10:01 PM
This review provides an overview of the structure and biological function of SET domain-containing 2 (#SETD2) and summarizes the implication of SETD2 dysregulation in #immunedisorders and the progress of several #epigeneticdrugs that target SETD2. #medsky
#OpenAccess: buff.ly/uGOcth3
#OpenAccess: buff.ly/uGOcth3